Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
29.71
-1.11 (-3.60%)
At close: Sep 5, 2025, 4:00 PM
29.70
-0.01 (-0.03%)
After-hours: Sep 5, 2025, 4:42 PM EDT
Astrana Health Stock Forecast
Stock Price Forecast
The 7 analysts that cover Astrana Health stock have a consensus rating of "Strong Buy" and an average price target of $53.29, which forecasts a 79.37% increase in the stock price over the next year. The lowest target is $36 and the highest is $70.
Price Target: $53.29 (+79.37%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 1, 2025.
Analyst Ratings
The average analyst rating for Astrana Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Initiates $36 | Hold | Initiates | $36 | +21.17% | Apr 1, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $50 → $46 | Strong Buy | Maintains | $50 → $46 | +54.83% | Mar 18, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $55 → $49 | Strong Buy | Maintains | $55 → $49 | +64.93% | Mar 4, 2025 |
| Baird | Baird | Buy Maintains $86 → $50 | Buy | Maintains | $86 → $50 | +68.29% | Mar 3, 2025 |
| Stifel | Stifel | Strong Buy Maintains $70 → $56 | Strong Buy | Maintains | $70 → $56 | +88.49% | Feb 20, 2025 |
Financial Forecast
Revenue This Year
3.27B
from 2.03B
Increased by 60.77%
Revenue Next Year
4.15B
from 3.27B
Increased by 26.90%
EPS This Year
1.31
from 0.90
Increased by 45.95%
EPS Next Year
2.08
from 1.31
Increased by 58.46%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.4B | 4.4B | |||
| Avg | 3.3B | 4.2B | |||
| Low | 3.1B | 3.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 68.3% | 35.9% | |||
| Avg | 60.8% | 26.9% | |||
| Low | 53.3% | 14.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.67 | 2.84 | |
| Avg | 1.31 | 2.08 | |
| Low | 1.04 | 1.37 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 85.5% | 115.8% | |
| Avg | 45.9% | 58.5% | |
| Low | 15.4% | 4.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.